''Within the next 2 years we will be closely observing whether the...
Category:
Eco/Invest/Demography
Latest
RBI shifts 100 tonnes of gold from vaults in UK to India to save storage cost
The central bank held 822.10 tonnes of gold as part of its foreign...
Online payment frauds jump over 400% in India:RBI data
"Fraudsters are getting sophisticated by the day, while financial...
Have to assume pandemic is going to get worse: Fauci
Fauci’s comments on Tuesday came after the US registered a record high 65,000 deaths in the past 28 days, making December the worst month for coronavirus fatalities since the start of the pandemic.
December’s figure, roughly equivalent to over 1.6 Americans lost to the virus every minute, marked a significant surge from that in the entire month of November which registered 36,964 fatalities.
The country’s overall the overall death toll currently stood at 338,544, the highest in the world, according to the Johns Hopkins University.
China’s Fosun plans plant to make BioNTech’s COVID-19 vaccine: Caixin
Fosun Pharma had said it aims to move from importing finished vaccine from the German company to conducting some filling procedures on its own, using imported bulk ingredients and then eventually making vaccines from scratch, though it has not announced a specific timeline.
Study uncovers blood vessel damage, inflammation in COVID-19 patients’ brains
The researchers saw no signs of infection in the brain tissue samples even though they used several methods for detecting genetic material or proteins from SARS-CoV-2.
“So far, our results suggest that the damage we saw may not have been not caused by the SARS-CoV-2 virus directly infecting the brain,” said Dr. Nath. “In the future, we plan to study how COVID-19 harms the brain’s blood vessels and whether that produces some of the short- and long-term symptoms we see in patients.”
AXA to sell its Greece operations for €165 million
Paris: AXA announced today that it has entered into an agreement with Generali to sell its insurance operations in Greece. Under the terms of the agreement, AXA will sell its Life & Savings and Property & Casualty businesses in Greece for a total cash...
India drug regulator approves AstraZeneca COVID vaccine, country’s first
Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.
The Central Drugs Standard Control Organization is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.
IFSCA becomes member of International Organization of Securities Commissions
The membership of IOSCO would provide IFSCA the platform to exchange information at the global level and regional level on areas of common interests.
WHO emergency COVID-19 vaccine listing aims to lift access in poor countries
The United Nations health agency said it will work with regional partners to tell national health authorities about the two-dose shot and its anticipated benefits.
The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like COVID-19, which otherwise could lead to delays.
Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
President-elect Biden has also vowed to reduce drug costs and to allow Medicare, a U.S. government health insurance program, to negotiate drug prices. He has support from Congressional Democrats to pass such legislation, which the Congressional Budget Office has said could cost the industry more than $300 billion by 2029.
BioNTech founders warn of vaccine supply gaps – Spiegel
“At the moment it doesn’t look good – a hole is appearing because there’s a lack of other approved vaccines and we have to fill the gap with our own vaccine,” BioNTech CEO Ugur Sahin told news weekly Spiegel.
Coronavirus vaccines could have potential allergic reactions, assures new studyBoston
The study published in the Journal of Allergy and Clinical Immunology, in response to accounts of potential allergic reactions in some people following COVID-19 vaccination in the United Kingdom, that country’s medical regulatory agency advised that individuals with a history of anaphylaxis to medicine or food should avoid COVID-19 vaccination.